Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...

MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.

UB researcher Murali Ramanathan has used artificial intelligence (AI) since its nascent days while exploring possible treatments for multiple sclerosis (MS) and Alzheimer’s disease. Today, Ramanathan, ...

Schrödinger (SDGR) stock and Revvity (RVTY stock are in focus as firms join Eli Lilly (LLY) to integrate their software with ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...

BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced it has won the ...

Medra, an artificial intelligence startup focused on drug discovery, has raised $52 million in early-stage funding to try to integrate powerful large language models with physical systems that can ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Thinking about AI and how it’s changing everything? It’s a big topic, and a lot of that change comes down to the hardware ...